Correlation Between MediciNova and Foghorn Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Foghorn Therapeutics, you can compare the effects of market volatilities on MediciNova and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Foghorn Therapeutics.

Diversification Opportunities for MediciNova and Foghorn Therapeutics

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between MediciNova and Foghorn is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Foghorn Therapeutics go up and down completely randomly.

Pair Corralation between MediciNova and Foghorn Therapeutics

Given the investment horizon of 90 days MediciNova is expected to generate 2.82 times more return on investment than Foghorn Therapeutics. However, MediciNova is 2.82 times more volatile than Foghorn Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  163.00  in MediciNova on August 28, 2024 and sell it today you would earn a total of  45.00  from holding MediciNova or generate 27.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Foghorn Therapeutics

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.
Foghorn Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Foghorn Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Foghorn Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

MediciNova and Foghorn Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Foghorn Therapeutics

The main advantage of trading using opposite MediciNova and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.
The idea behind MediciNova and Foghorn Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements